Why get 5 or 10 years when you can get 15 years recurrence data? 15 year Treatment Planning tool
Cancer recurrence, that means cancer returns. If you are fighting against Breast cancer have you ever wonder is there a risk of recurrence.
It is believed that the risk of breast cancer recurrence is highest over 2 years of initial diagnosis, and as time passes it steadily decreases. Breast cancer individual celebrates their 5 years of survival against cancer, as it is believed that the recurrence after 5 years is relatively low. Regional recurrence usually happens over 5 years of initial diagnosis and is considered as early recurrence. Although late recurrence also occurs, this is beyond 5 years of diagnosis.
“Even though the women remained free of recurrence in the first five years, the risk of having their cancer recurrence elsewhere (for example in the bone, liver, and lung) from years 5 to 20 remains constant.” – Daniel F Hayes. MD (ASCO member since 1986).
Studies have evidence that there is a considerable percentage risk for breast cancer recurrence over 15 years, although individuals with larger tumors and affected lymph nodes are at higher risk than individuals with smaller tumors and none affected lymph nodes, for having breast cancer recurrence over 15 years.
Since there are advanced and emergent new diagnostics techniques that would help you analyse your disease. Many new risk assessment tests have boosted the diagnostic industries and are available for human health development.
Tests such as EndoPredict, Mamma Print, Oncotype dx, gives you your recurrence risk analysis. Though not all would give you 15 years recurrence risk. EndoPredict is the only one that would assist you with your 15 years of recurrence risk, whereas Mamma Print gives 5 years recurrence risk and Oncotype dx gives you 9 years recurrence risk.
